Sentinel Oncology, Oncothyreon Collaborate on Small Molecule Chk1 Inhibitors

News   Apr 22, 2014

 
Sentinel Oncology, Oncothyreon Collaborate on Small Molecule Chk1 Inhibitors
 
 
 

RELATED ARTICLES

Researchers Create Remote-Controlled Cancer Immunotherapy System

News

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

READ MORE

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

Targeted Cancer Treatment Could be Possible Thanks to Insights into Cells’ Energy Supply

News

Researchers have shown that the enzyme EXD2 is critically involved in maintaining efficient protein production in mitochondria - the compartment responsible for making the energy required for cells to survive and replicate.


It is hoped the discovery could be used to target tumours in cancer patients in a new way while also significantly adding to the understanding of the vital role mitochondria plays in the functioning of a healthy cell.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE